Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frankincense Gel is a topical botanical formulation containing extracts of *Boswellia serrata* (frankincense), currently being evaluated for its wound-healing and anti-inflammatory properties in dental surgery. Developed and studied by researchers at Cairo University, the gel is applied to palatal donor site wounds following soft tissue graft harvesting, such as free gingival or connective tissue grafts. The therapeutic effect is attributed to the presence of boswellic acids, which are known to promote epithelialization and reduce postoperative pain by modulating the inflammatory response. In clinical trial settings, it is often used in conjunction with a palatal stent to protect the surgical site and enhance tissue repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on frankincense gel.